The long elusive IgM Fc receptor, FcμR

Journal of Clinical Immunology

Volumn 34, Issue SUPPL. 1, 2014, Pages

  Kubagawa, Hiromi ^a   Oka, Satoshi ^a,b   Kubagawa, Yoshiki ^a   Torii, Ikuko ^a,c   Takayama, Eiji ^a,d   Kang, Dong Won ^a,e   Jones, Dewitt ^a   Nishida, Naonori ^f   Miyawaki, Toshio ^f   Bertoli, Luigi F ^g   Sanders, Sheila K ^a   Honjo, Kazuhito ^a  

^a University of Alabama at Birmingham   (United States)

^b Hematology and Oncology Shiga Medical Center for Adults   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d ASAHI UNIVERSITY   (Japan)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TOYAMA   (Japan)

^g Brookwood Medical Center Birmingham   (United States)

Author keywords

B cells; Chronic lymphocytic leukemia; Fc receptor; IgM; T cells

Indexed keywords

AUTOANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M RECEPTOR;

ANIMAL; B LYMPHOCYTE; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; ISOLATION AND PURIFICATION; MOUSE;

ANIMALS; AUTOANTIGENS; B-LYMPHOCYTES; HUMANS; IMMUNOGLOBULIN M; IMMUNOMODULATION; MICE; RECEPTORS, FC;

EID: 84905186245     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0022-7     Document Type: Review

References (68)

1. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol. 1991;9:457-92.
2. Daëron M. Fc receptor biology. Annu Rev Immunol. 1997;15:203-34.
3. Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol. 2003;21:177-204. (Pubitemid 37174530)
4. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. FcγRIV: a novel FcR with distinct IgG subclass specificity. Immunity. 2005;23(1):41-51. (Pubitemid 41019656)
5. Kubagawa H, Oka S, Kubagawa Y, Torii I, Takayama E, Kang DW, et al. Identity of the elusive IgMFc receptor (FcμR) in humans. J Exp Med. 2009;206(12):2779-93.
6. Honjo K, Kubagawa Y, Jones DM, Dizon B, Zhu Z, Ohno H, et al. Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR). Proc Natl Acad Sci U S A. 2012;109(39):15882-7.
7. Moretta L, Webb SR, Grossi CE, Lydyard PM, Cooper MD. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM (Tμ) or IgG (Tγ). J Exp Med. 1977;146(1):184-200. (Pubitemid 8139502)
8. Reinherz EL, Moretta L, Roper M, Breard JM, Mingari MC, Cooper MD, et al. Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies: a comparison. J Exp Med. 1980;151(4):969-74. (Pubitemid 10118533)
9. Sanders SK, Kubagawa H, Suzuki T, Butler JL, Cooper MD. IgM binding protein expressed by activated B cells. J Immunol. 1987;139(1):188-93. (Pubitemid 17091783)
10. Ohno T, Kubagawa H, Sanders SK, CooperMD. Biochemical nature of an Fcμ receptor on human B-lineage cells. J Exp Med. 1990;172(4):1165-75. (Pubitemid 20343217)
11. Nakamura T, Kubagawa H, Ohno T, CooperMD. Characterization of an IgM Fc-binding receptor on human T cells. J Immunol. 1993;151(12):6933-41. (Pubitemid 24001068)
12. Vire B, David A, Wiestner A. TOSO, the Fcμ receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation. J Immunol. 2011;187(8):4040-50.
13. Pricop L, Rabinowich H, Morel PA, Sulica A, Whiteside TL, Herberman RB. Characterization of the Fcμ receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects. J Immunol. 1993;151(6):3018-29. (Pubitemid 23282614)
14. Nguyen XH, Lang PA, Lang KS, Adam D, Fattakhova G, Foger N, et al. Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood. 2011;118(3):598-608.
15. Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ, et al. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 1998;8(4):461-71. (Pubitemid 28196800)
16. Honjo K, Kubagawa Y, Kubagawa H. Is Toso an antiapoptotic protein or an Fc receptor for IgM? Blood. 2012;119(7):1789-90.
17. Murakami Y, Narayanan S, Su S, Childs R, Krzewski K, Borrego F, et al. Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells. J Immunol. 2012;189(2):587-97.
18. Hamburger AE, West Jr AP, Bjorkman PJ. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure. 2004;12(11):1925-35. (Pubitemid 39469390)
19. Hoover RG, Dieckgraefe BK, Lynch RG. T cells with Fc receptors for IgA: induction of T alpha cells in vivo and in vitro by purified IgA. J Immunol. 1981;127(4):1560-3. (Pubitemid 11021043)
20. Reljic R. In search of the elusive mouse macrophage Fcα receptor. Immunol Lett. 2006;107(1):80-1. (Pubitemid 44332542)
21. Maruoka T, Nagata T, Kasahara M. Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics. 2004;55(10):712-6. (Pubitemid 38221671)
22. Adachi T, Harumiya S, Takematsu H, Kozutsumi Y, Wabl M, Fujimoto M, et al. CD22 serves as a receptor for soluble IgM. Eur J Immunol. 2012;42(1):241-7.
23. Poe JC, Tedder TF. CD22 and Siglec-G in B cell function and tolerance. Trends Immunol. 2012;33(8):413-20.
24. McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, James LC. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol. 2013;14(4):327-36.
25. Randow F, MacMicking JD, James LC. Cellular self-defense: how cell-autonomous immunity protects against pathogens. Science. 2013;340(6133):701-6.
26. Tissot JD, Sanchez JC, Vuadens F, Scherl A, Schifferli JA, Hochstrasser DF, et al. IgM are associated to Sp alpha (CD5 antigen-like). Electrophoresis. 2002;23(7-8):1203-6.
27. Martinez VG, Moestrup SK, Holmskov U, Mollenhauer J, Lozano F. The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev. 2011;63(4):967-1000.
28. Miyazaki T, Kurokawa J, Arai S. AIMing at metabolic syndrome. Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM). Circ J. 2011;75(11):2522-31.
29. Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, et al. Obesity-associated autoantibody production requires AIM to retain the immunoglobulinMimmune complex on follicular dendritic cells. Cell Rep. 2013;3(4):1187-98.
30. Reth M. Antigen receptor tail clue. Nature. 1989;338(6214):383-4.
31. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell. 1994;76(2):263-74. (Pubitemid 24046689)
32. Cambier JC. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol. 1995;155(7):3281-5.
33. Vely F, Vivier E. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J Immunol. 1997;159(5):2075-7. (Pubitemid 127680992)
34. Cambier JC. Inhibitory receptors abound? Proc Natl Acad Sci U S A. 1997;94(12):5993-5. (Pubitemid 27270622)
35. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol. 2003;4(1):19-24. (Pubitemid 36104703)
36. Engels N, Konig LM, Heemann C, Lutz J, Tsubata T, Griep S, et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol. 2009;10(9):1018-25.
37. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad Jr J, Miljkovic V, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A. 2003;100(5):2639-44. (Pubitemid 36297551)
38. Riou C, Yassine-Diab B, van Grevenynghe J, Somogyi R, Greller LD, Gagnon D, et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med. 2007;204(1):79-91. (Pubitemid 46148759)
39. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44-9.
40. Shibuya A, Sakamoto N, Shimizu Y, Shibuya K, Osawa M, Hiroyama T, et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat Immunol. 2000;1(5):441-6.
41. Kikuno K, Kang DW, TaharaK, Torii I, Kubagawa HM, HoK J, et al. Unusual biochemical features and follicular dendritic cell expression of human Fcα/μ receptor. Eur J Immunol. 2007;37(12):3540-50.
42. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205(8):1797- 805.
43. Pichler WJ, Knapp W. Receptors for IgM-coated erythrocytes on chronic lymphatic leukemia cells. J Immunol. 1977;118(3):1010-5. (Pubitemid 8064689)
44. Ferrarini M, Hoffman T, Fu SM, Winchester R, Kunkel HG. Receptors for IgM on certain human B lymphocytes. J Immunol. 1977;119(4):1525-9. (Pubitemid 8214779)
45. Burns GF, Cawley JC, Barker CR. Characterization of the receptor for IgMpresent on human B lymphocytes. Immunology. 1979;36(3):569-77. (Pubitemid 9249541)
46. Rudders RA, Andersen J, Howard JP, Fried R. The binding of IgM to B lymphocytes. I. Studies of the binding of aggregated IgMto normal and leukemic human B lymphocytes. Clin Immunol Immunopathol. 1980;15(4):673-86. (Pubitemid 10181911)
47. Platsoucas CD, Kempin S, Karanas A, Clarkson B, Good RA, Gupta S. Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. Clin Exp Immunol. 1980;40(2):256-63. (Pubitemid 10113458)
48. Proto-Siqueira R, Panepucci RA, Careta FP, Lee A, Clear A, Morris K, et al. SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. Blood. 2008;112(2):394-7.
49. Pallasch CP, Schulz A, Kutsch N, Schwamb J, Hagist S, Kashkar H, et al. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Blood. 2008;112(10):4213-9.
50. Pallasch CP, Wendtner CM. Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia. Leuk Lymphoma. 2009;50(3):498-501.
51. Li FJ, Kubagawa Y, McCollum MK, Wilson L, Motohashi T, Bertoli LF, et al. Enhanced levels of both membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia. Blood. 2011;118(18):4902-9.
52. Duhren-von MM, Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489(7415):309-12.
53. Stevenson FK, Hamblin TJ, Stevenson GT, Tutt AL. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med. 1980;152(6):1484-96. (Pubitemid 11210330)
54. Qian GX, Fu SM, Solanki DL, Rai KR. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM. J Immunol. 1984;133(6):3396-400. (Pubitemid 15216524)
55. Bertoli LF, Kubagawa H, Borzillo GV, Mayumi M, Prchal JT, Kearney JF, et al. Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter 's syndrome). Blood. 1987;70(1):45-50. (Pubitemid 17111239)
56. Chiorazzi N, Rai KR, FerrariniM. Chronic lymphocytic leukemia. N Engl J Med. 2005;352(8):804-15.
57. Lang KS, Lang PA, Meryk A, Pandyra AA, Boucher LM, Pozdeev VI, et al. Involvement of Toso in activation of monocytes, macrophages, and granulocytes. Proc Natl Acad Sci U S A. 2013;110(7):2593-8.
58. Honjo K, Kubagawa Y, Kubagawa H. Is Toso/IgM Fc receptor (FcμR) expressed by innate immune cells? Proc Natl Acad Sci U S A. 2013;110(28):E2540- 1.
59. Ouchida R, Mori H, Hase K, Takatsu H, Kurosaki T, Tokuhisa T, et al. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc Natl Acad Sci U S A. 2012;17:E2699-706.
60. Choi SC, Wang H, Tian L, Murakami Y, Shin DM, Borrego F, et al. Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J Immunol. 2013;190(3):987-96.
61. Ehrenstein MR, Notley CA. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol. 2010;10(11):778-86.
62. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol. 1998;160(10):4776-87. (Pubitemid 28215311)
63. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A. 1998;95(17):10089-93. (Pubitemid 28415299)
64. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin Min immediate defense against systemic bacterial infection. J Exp Med. 1998;188(12):2381-6. (Pubitemid 29028511)
65. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med. 2000;192(2):271-80. (Pubitemid 30470309)
66. Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol. 2010;184(10):5755-67.
67. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J.Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A. 2000;97(3):1184-9. (Pubitemid 30080833)
68. Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med. 2000;191(7):1253-8.